Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atyr Pharma Inc
(NQ:
LIFE
)
1.240
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atyr Pharma Inc
< Previous
1
2
3
4
Next >
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
The "Diya Jalao Roshni Lao" campaign was initiated by the Beat of Life Entertainment company in 2022. Its aim is to draw people's attention to our culture, the hard work of potters, hope, their lives,...
Via
IssueWire
Topics
Religion
Exposures
Religion
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
Multiple centers in the U.S. are open for enrollment
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via
Benzinga
The Latest Analyst Ratings for aTyr Pharma
May 23, 2023
Via
Benzinga
aTyr Pharma: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
Where aTyr Pharma Stands With Analysts
March 10, 2023
Via
Benzinga
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 02, 2023
The Dow Jones closed higher on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks...
Via
Benzinga
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
July 05, 2023
Oppenheimer has downgraded aTyr Pharma Inc (NASDAQ: LIFE) to Perform from Outperform, citing a few material catalysts in the next few quarters.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023
July 05, 2023
Via
Benzinga
aTyr Pharma's Earnings: A Preview
March 08, 2023
Via
Benzinga
aTyr Pharma: Q2 Earnings Insights
August 15, 2022
aTyr Pharma (NASDAQ:LIFE) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
June 28, 2023
Bard AI has consistently outperformed, and it has identified seven growth stocks that it believes will deliver triple-digit returns.
Via
InvestorPlace
3 Stocks and Cryptos With the Highest Potential Returns
May 07, 2023
If you're only worried about upside, these stocks and cryptos have some of the highest possible returns in the market.
Via
InvestorPlace
7 Hot Growth Stocks Poised to Triple in 2023
May 05, 2023
These hot growth stocks to buy can triple in price in 2023, with some holding impressive upside that's much higher.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 09, 2023
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis?
November 29, 2022
Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
On Friday, 64 companies achieved new lows for the year.
Via
Benzinga
Beat Of Life Entertainment- A One Stop Solution For Internet Marketing
October 08, 2022
Internet marketing is the solution for business development in the digitalization era.
Via
IssueWire
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate
September 13, 2022
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 13, 2022
Via
Benzinga
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
August 16, 2022
Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.
Via
Benzinga
A Preview Of aTyr Pharma's Earnings
August 12, 2022
aTyr Pharma (NASDAQ:LIFE) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that aTyr Pharma...
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.